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Columbia University, New York, New York, USA 
Background: Elevated levels of the pesticide DDT (dichlorodiphenyltrichloroethane) have been 
positively associated with blood pressure and hypertension in studies among adults. Accumulating 
epidemiologic and toxicologic evidence suggests that hypertension during adulthood may also be 
affected by earlier life and possibly the prenatal environment.
oBjectives: We assessed whether prenatal exposure to the pesticide DDT increases risk of adult 
hypertension.
Methods: We examined concentrations of DDT (p,p´- and o,p´-) and its metabolite p,p´-DDE 
(dichlorodiphenyldichloroethylene) in prenatal serum samples from a subset of women (n = 527) 
who had participated in the prospective Child Health and Development Studies birth cohort 
in the San Francisco Bay area while they were pregnant between 1959 and 1967. We surveyed 
daughters 39–47 years of age by telephone interview from 2005 to 2008 to obtain information on 
self-reported physician-diagnosed hypertension and use of hypertensive medication. We used multi-
variable regression analysis of time to hypertension based on the Cox proportional hazards model to 
estimate relative rates for the association between prenatal DDT exposures and hypertension treated 
with medication in adulthood, with adjustment for potential confounding by maternal, early-life, 
and adult exposures.
results: Prenatal p,p´-DDT exposure was associated with hypertension [adjusted hazard ratio 
(aHR) = 3.6; 95% CI: 1.8, 7.2 and aHR = 2.5; 95% CI: 1.2, 5.3 for middle and high tertiles of 
p,p´-DDT relative to the lowest tertile, respectively]. These associations between p,p´-DDT and 
hypertension were robust to adjustment for independent hypertension risk factors as well as sensi-
tivity analyses.
conclusions: These findings suggest that the association between DDT exposure and hyperten-
sion may have its origins early in development.
key words: blood pressure, DDT, hypertension, life course, prenatal. Environ Health Perspect 
121:594–599 (2013). http://dx.doi.org/10.1289/ehp.1205921 [Online 12 March 2013]
Hypertension is a costly and  debilitating health 
problem in countries worldwide, and the 
preva lence of hypertension is rising. Population 
prevalence rates of > 20% have been reported 
in the United States, Venezuela, South Africa, 
and Lebanon, and rates of close to 50% have 
been reported in Germany and Spain (Arnaout 
et al. 2011; Hernandez-Hernandez et al. 
2000). Increases in the prevalence of hyper-
tension are generally attributed to changes 
in the prevalence of known preventable risk 
factors and to demographic shifts in popula-
tions. There is growing evidence that chemical 
exposures may also be associated with hyper-
tension. For example, in a cohort study of 
pesticide applicators occupationally exposed 
to dichlorodiphenyltrichloroethane (DDT), 
mean serum levels of DDT and its metabo-
lite dichlorodiphenyldichloroethylene (DDE) 
were significantly higher in persons who sub-
sequently developed hypertension than in 
those who were normotensive (Morgan et al. 
1980). More recently, the concentration of 
p,p´-DDT in breast milk was associated with 
increased maternal systolic blood pressure 
(Siddiqui et al. 2002). Despite the ubiquity 
of DDT and DDE in human tissues due to 
malaria prevention and environmental con-
tamination, the possible contribution of these 
exposures to the global spread of hypertension 
has not been quantified.
There is extensive evidence that the envi-
ronment during early development influences 
the risk of adult hypertension. In humans, low 
birth weight is associated with increased preva-
lence of adult hypertension (Barker et al. 1990; 
Leon et al. 1996). In animals, prenatal exposure 
to undernutrition, high-fat diet/ adiposity, and 
glucocorticoids have all been associated with 
increased hypertension in offspring (Alwasel 
and Ashton 2009; Armitage et al. 2005; 
Gwathmey et al. 2011). These findings gave 
rise to the developmental origins of health and 
disease model, where “causes to be identified 
are linked to normal variations in fetoplacental 
and infant development” (Barker 2012).
Our a priori hypothesis was that pre natal 
exposure to DDT increases the risk of hyper-
tension in adult life. We estimated the associa-
tion between adult hypertension and prenatal 
DDT exposure in a prospective multiyear birth 
cohort study of women in the San Francisco 
Bay area, California, followed longitudinally 
from the prenatal period into their fifth decade 
(mean follow-up, 43.7 years).
Methods
Populat ion .  The  Chi ld  Hea l th  and 
Development Studies (CHDS) is a pregnancy 
cohort designed to examine the association 
between prenatal exposures and health and 
development over the life course for parents 
and children. The CHDS recruited women 
residing in the Oakland, California, area 
who were members of the Kaiser Permanente 
Foundation Health Plan and who sought 
obstetric care for pregnancies between 1959 
and 1967 (van den Berg et al. 1988). CHDS 
participants gave oral informed consent for an 
in-person interview and collection of blood 
specimens at the first prenatal visit, in each 
trimester, and shortly after delivery (usually 
within 1–3 days), and gave permission for 
access to their own medical records and also 
their children’s medical records.
The present study of prenatal DDT 
exposure and adult hypertension used data 
collected for a cohort study of early-life pre-
dictors of breast density that was nested within 
the CHDS cohort. In 2005, two groups of 
adult daughters of CHDS participants were 
recruited for the breast density study: a) those 
who had at least one sister enrolled in the 
CHDS (to facilitate control of family-level 
confounders such as socioeconomic status), 
and b) those who had a birth weight greater 
than the 90th percentile (> 3,835 g) for live-
born, singleton female births in the CHDS 
cohort (to facilitate an analysis of the asso-
ciation between high birth weight and breast 
density) (Terry et al. 2011). Additional eli-
gibility requirements were available data on 
birth length and weight, at least one same-
day childhood height and weight measure 
between 6 months and 5.5 years of age, 
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maternal interview data, and prenatal serum. 
The breast density study was conducted with 
daughters’ informed consent at the time of 
their telephone interview and was approved 
by the institutional review boards of Columbia 
University and the Public Health Institute; 
the latter also oversees the continuing research 
based on the original families in the study and 
their now adult offspring. Mount Sinai School 
of Medicine deemed the present study not 
human subjects research. This study is in com-
pliance with all federal guidelines governing 
studies of human participants.
Variables. At the CHDS baseline, each 
mother was interviewed in person to determine 
her race/ethnicity, parity, age at the time of 
pregnancy, date of last menstruation, pre-
pregnancy body mass index (BMI), country of 
birth, and educational attainment. BMI at the 
first prenatal visit and gestational weight gain 
over the course of pregnancy were determined 
from maternal medical records. Maternal medi-
cal records were further examined to identify 
maternal physician-coded diabetes and pre-
eclampsia, as well as daughters’ birth weight. We 
determined gesta tional age from mother’s report 
of last menstrual period and medi cal record 
report of infant’s date of birth. We evaluated 
daughters’ birth weight as a con tinuous variable 
and categorized as low (< 2,500 g) or normal 
according to the World Health Organization 
definition (Blanc and Wardlaw 2005).
We obtained data from adult daughters 
during telephone interviews conducted in 
2005–2008 (Terry et al. 2011). Daughters 
reported their diabetes status, weight, height, 
race/ethnicity, educa tional attainment, annual 
house hold income, age, and menopausal sta-
tus. Diabetes status was defined as a doctor 
ever or never telling a participant she had 
diabetes. Annual household income included 
salaries and all other sources. Participants were 
deemed pre menopausal if they had a menstrual 
period within the preceding 12 months, peri-
menopausal if they had 60 days of amenor rhea 
of the preceding 12 months or between 2 and 
< 12 months passed since their last menstrual 
period, and postmenopausal if they either 
reported surgical menopause or had their last 
menstrual period > 365 days before interview. 
We calculated the BMI (kilograms per meter 
squared) of daughters from their height and 
weight. For the primary analysis, we classified 
hypertension based on self-report of physician-
diagnosed hyper tension plus use of anti hyper-
tensive medica tion in response to the question 
“How old were you when you were first diag-
nosed with high blood pressure or hyper-
tension?” Age of hyper tension diag nosis was 
a self-reported response to the question “How 
old were you when you were first diag nosed 
with high blood pressure or hypertension?”
Laboratory assays. DDT-related com-
pounds (p,p´-DDT, o,p´-DDT, p,p´-DDE; 
collectively herein DDTs) were solid phase 
extracted from one maternal sample collected 
during either during the third trimester or 
within 1–3 days of delivery between 1959 and 
1967 (Brock et al. 1996; Cohn et al. 2003; 
Gammon et al. 2002). There is a high degree of 
correlation between organochlorine chemicals 
levels in samples collected across prenatal and 
neonatal periods within a woman (Longnecker 
et al. 1999). Maternal sera triglycerides and 
total cholesterol were analyzed enzymatically 
as described in prior publications (Cohn et al. 
2007, 2010).
Statistical analyses. We categorized DDTs 
into tertiles for analyses, with tertile bound-
aries of 6.97 and 11.9 μg/L for p,p´-DDT, 
0.24 and 0.51 μg/L for o,p´-DDT, and 37 and 
54 μg/L for p,p´-DDE. We conducted bivari-
ate analyses to examine associations between 
p,p´-DDT exposure and possible confound-
ers while accounting for the possible depen-
dence between siblings in the analysis sample, 
using multinomial generalized linear models 
for cate gorical factors (PROC GENMOD, 
PROC FREQ, SAS version 9.2; all programs 
from SAS Institute Inc., Cary, NC) and gen-
eralized linear models for continuous factors 
(PROC MIXED). Life table curves for time to 
medicated hypertension onset by p,p´-DDT 
tertile were drawn using the unadjusted data 
(PROC LIFETEST). 
We estimated associations [hazard ratios 
(HRs)] between tertiles of prenatal DDTs and 
daughters’ hypertension with multi variable 
regression analysis of time to self-reported 
hypertension diagnosis based on the Cox pro-
portional hazards model using robust variance 
estimation to account for the correlated nature 
of siblings (PROC PHREG). Participants 
who did not report age at hypertension diag-
nosis were censored at their age at interview. 
Our model selection strategy was designed 
to address a single research question: Is there 
evidence of an association between prenatal 
exposure to DDTs and hypertension?
First we estimated unadjusted HR for 
medicated hypertension among women in the 
second and third tertiles of each DDT com-
pound (p,p´-DDT, o,p´-DDT and p,p´-DDE) 
compared with the lowest tertile (model 1). 
Additionally, we constructed three multi-
variable models adjusted for maternal factors 
(model 2), adult risk factors (model 3), and 
the combination of these factors (model 4) 
(Lucas et al. 1999). For model 2 we con-
sidered potential confounding by maternal 
race/ ethnicity, age, parity, country of birth, 
BMI, triglycerides, total cholesterol, pre-
eclampsia, and gestational weight gain. The 
final model was adjusted for maternal race/
ethnicity (African American vs. all other races, 
or Hispanic) only, using a 10% change in 
the point estimates for DDTs as the crite-
rion for retaining potential confounders in 
the model (Maldonado and Greenland 1993). 
For model 3 we considered daughters’ race/
ethnicity (African American vs. all other races, 
or Hispanic), age at interview, menopausal 
status (pre-, peri-, or postmenopausal), BMI 
(continuous), and diabetes status (ever or 
never) as potential confounders, and retained 
BMI, diabetes, menopausal status, and race/
ethnicity using p < 0.05 for the association 
between the covariate and hypertension as the 
criterion for retention. Last, we examined a 
multivariable model 4, combining early-life 
confounding (model 2) and contemporary 
risk factors (model 3).
Because p,p´-DDT has been associated 
with birth weight and decreased birth weight 
is associated with increased risk of hyper-
tension, we examined whether birth weight 
mediated our observed association between 
prenatal p,p´-DDT exposure and adult hyper-
tension (Leon et al. 1996; Lopez-Espinosa et al. 
2011). We considered birth weight a mediator 
of the p,p´-DDT exposure if it reduced the 
p,p´-DDT effect size. In addition, to assess 
whether BMI modified the association between 
hypertension and p,p´-DDT exposure, we 
examined multiplicative interaction between 
prenatal p,p´-DDT exposure and either mater-
nal or daughter overweight and obesity (BMI 
> 25) (La Merrill and Birnbaum 2011).
We conducted sensitivity analyses of alter-
native DDT exposure variables dichotomized 
at the median or categorized into quartiles, 
and ran models that were mutually adjusted 
for all DDTs in addition to separate models of 
each. As evidenced from the unadjusted data 
in Figure 1, there was a nonlinear relation-
ship between p,p´-DDT and medicated hyper-
tension. We considered categorizing DDTs 
by the median, tertiles, and quartiles before 
multivariable analyses. Although all categories 
produced similar results, we grouped DDTs 
into tertiles to facilitate development of target 
exposure thresholds in public health practices 
while maintaining analytical power. We also 
Figure 1. Unadjusted probability of being outcome-
free as a function of prenatal p,p´-DDT tertile 
(n = 527 women). Outcome-free is defined by self- 
report of not having been treated for hypertension 
and censored at age at interview, whereas the out-
come is defined by self-reported age at diagnosis 
of medicated hypertension. 
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estimated associations with all cases of self-
reported hypertension, in addition to primary 
analyses of cases restricted to women who 
reported use of anti hypertensive medications. 
Our a priori expectation was that the effect 
of p,p´-DDT exposure on hypertension risk 
would be strengthened in hypertension severe 
enough to warrant medication use because it is 
biologically plausible. To investigate whether 
oversampling high-birth-weight daughters 
influenced associations, we also modeled data 
after excluding the oversampled daughters with 
birth weight > 3,835 g. To investigate whether 
sibship influenced results, we also compared 
associations in the full sample with associations 
in all nonsisters plus a) the oldest sister from 
each sibling set or b) the second-born sister 
from each sibling set.
Results
The CHDS recruited 15,528 mothers who 
received obstetric care through the Oakland, 
California, Kaiser Foundation Hospital for 
20,754 pregnancies between 1959 and 1967. 
More than 90% of those eligible participated 
in the CHDS. From 2005 through 2008, 
80% of the 1,526 daughters who were eli-
gible for the breast density study were suc-
cessfully traced, and 85% of traced daughters 
participated. Of the 527 women for whom 
DDTs, hypertension status, diabetes status, 
and BMI data were available, 156 were part 
of the high-birth-weight oversample, 70 were 
nonsisters, 301 were sisters (140 sets of pairs 
and 7 sets of “threes”), and 70 reported taking 
anti hypertensive medication due to physician-
 diagnosed hypertension at the time of inter-
view. Table 1 shows the distributions of 
potential confounders according to p,p´-DDT 
tertiles in the study population. Proportionally 
more African-American women were in the 
highest tertile of pre natal p,p´-DDT expo-
sure than other women. Mothers’ age at birth 
and daughters’ age at interview were high-
est among women in the highest p,p´-DDT 
tertile.
The unadjusted risk of medicated hyper-
tension was increased substantially among 
women with prenatal p,p´-DDT in the highest 
two tertiles of the study population (Figure 1). 
There were fewer cases of medicated hyper-
tension among women in the lowest tertile 
of prenatal exposure to each of the DDTs 
compared with their respective higher tertiles 
(Table 2). The unadjusted prevalence of medi-
cated hypertension which arose in women 
< 35 years old was 4.0% among women with 
prenatal p,p´-DDT in the highest two tertiles 
of the study population and only 0.6% in the 
lowest tertile. When we adjusted for confound-
ing by maternal race/ethnicity in model 2, 
adjusted hazard ratios (aHR) for the middle 
and highest tertiles of prenatal p,p´-DDT 
exposure compared with the lowest tertile 
were 3.6 (95% CI: 1.8, 7.2) and 2.5 (95% CI: 
Table 1. Distribution of maternal, early-life, and adult characteristics by prenatal p,p´-DDT exposure ter-
tiles in 527 women of the CHDS [n (%) or LSM (95% CI)]. 
Characteristic Tertile 1 (n = 168) Tertile 2 (n = 182) Tertile 3 (n = 177)
Maternal and early-life
Race/ethnicity
African American* 20 (26) 20 (26) 36 (47)
White, Asian, Hispanic, other 148 (33) 162 (36) 141 (31)
Maternal BMI (kg/m2)a 23.2 (22.7, 23.8) 23.3 (22.8, 23.9) 23.7 (23.2, 24.2)
Maternal cholesterol (mg/dL)b 245.0 (233.2, 256.7) 241.1 (229.6, 252.7) 264.0 (252.3, 275.8)
Maternal triglycerides (mg/dL)b 199.0 (187.7, 211.3) 201.7 (189.6, 213.8) 217.8 (205.6, 230.1)**
Maternal preeclampsia
Present 4 (36) 3 (27) 4 (36)
Absent 164 (32) 179 (35) 173 (33)
Maternal age at birth (years) 26.9 (26.0, 27.7) 26.6 (25.7, 27.4) 28.5 (27.6, 29.3)
Birth weight (g)
≥ 2,500 166 (32) 175 (34) 173 (34)
< 2,500 7 (54) 4 (31) 2 (15)
≤ 3,835 123 (36) 115 (33) 107 (31)
> 3,835 50 (28) 64 (35) 68 (37)
Adult daughters
Race/ethnicity
African American* 21 (25) 22 (27) 40 (48)
White, Asian, Hispanic, other 152 (34) 157 (35) 135 (31)
Income ($US)c
< 25,000 11 (38) 6 (21) 12 (41)
25,000–49,999 31 (34) 31 (34) 28 (31)
50,000–99,999 62 (33) 56 (30) 70 (37)
≥ 100,000 57 (28) 83 (41) 62 (31)
Menopause
Premenopausal 129 (34) 133 (35) 119 (31)
Perimenopausal 27 (28) 31 (32) 38 (39)
Postmenopausal 12 (24) 18 (36) 20 (40)
Age at interview (years) 43.0 (42.7, 43.2) 43.8 (43.6, 44.0)** 44.3 (44.1, 44.6)**
BMI 27.1 (26.0, 28.2) 28.2 (27.2, 29.2) 27.7 (26.7, 28.8)
Diabetes status
Ever 9 (21) 18 (43) 15 (36)
Never 159 (33) 164 (34) 162 (33)
LSM, least square mean.
an = 497. bn = 526. cn = 509. *p < 0.05 association of categorical variable across all p,p´-DDT tertiles (PROC GENMOD). 
**p < 0.05 LSM of linear variables in p,p´-DDT tertile 1 as reference group (PROC MIXED).
Table 2. Hazard ratios (HRs) of the association between prenatal DDTs and daughters’ medicated hypertension.
DDTs
Normotensive 
(n)
Hypertensive 
(n)
HR (95% CI) p-value
Model 1 Model 2 Model 3 Model 4
p,p´-DDTa
Tertile 1 160 8 Reference Reference Reference Reference
Tertile 2 149 33 3.5 (1.7, 7.5) 0.0009 3.6 (1.9, 7.9) 0.0007 3.6 (1.8, 7.2) 0.0003 3.6 (1.8, 7.2) 0.0004
Tertile 3 148 29 2.9 (1.3, 6.4) 0.008 2.6 (1.2, 5.8) 0.02 2.5 (1.2, 5.3) 0.01 2.5 (1.2, 5.3) 0.01
o,p´-DDTb
Tertile 1 147 14 Reference Reference Reference Reference
Tertile 2 157 28 1.7 (0.9, 3.2) 0.10 1.6 (0.8, 3.0) 0.17 1.3 (0.7, 2.5) 0.44 1.3 (0.7, 2.5) 0.43
Tertile 3 153 27 1.6 (0.8, 3.0) 0.15 1.3 (0.7, 2.6) 0.39 1.2 (0.6, 2.2) 0.57 1.2 (0.6, 2.2) 0.54
p,p´-DDEa
Tertile 1 149 16 Reference Reference Reference Reference
Tertile 2 151 24 1.5 (0.8, 2.7) 0.24 1.3 (0.7, 2.5) 0.38 1.4 (0.8, 2.4) 0.30 1.4 (0.8, 2.4) 0.26
Tertile 3 157 30 1.7 (0.9, 3.2) 0.12 1.4 (0.7, 2.7) 0.30 1.6 (0.9, 2.9) 0.08 1.7 (1.0, 3.0) 0.06
Model 1: bivariate DDT analysis. Model 2 maternal covariables: race/ethnicity (African American/other). Model 3 daughter’s covariables: BMI (continuous), diabetes (ever/never), 
menopausal status (pre-/peri-/postmenopausal, race/ethnicity (African American/other). Model 4: model 2 + model 3. 
an = 527. bn = 52. 
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1.2, 5.3), respectively. Consistent with expec-
tations, medicated hypertension was associated 
with known risk factors including daughters’ 
race/ethnicity, menopausal status, BMI, dia-
betes, and age (data not shown), but only 
race/ ethnicity, menopausal status, BMI, and 
diabetes were retained in the final model 3 
based on p-values < 0.05, and associations 
based on this model were similar to those from 
model 2. Although both the model of early-
life confounding (model 2) and the model of 
contemporary risk factors that predicted 
daughter’s hypertension (model 3) were both 
included in model 4 (mothers’ race/ ethnicity, 
daughters’ race/ ethnicity, menopausal sta-
tus, BMI, and diabetes), only the covariables 
from model 3 remained significant, and the 
p,p´-DDT effect size remained comparable 
(Table 2). The other DDTs—o,p´-DDT and 
p,p´-DDE—were not significantly associated 
with medicated hypertension in any of the 
models (Table 2).
Birth weight as a continuous measure was 
not significantly associated with medicated 
hypertension (model 3 aHR = 1.00; 95% CI: 
0.99, 1.00), but low birth weight (< 2,500 g 
vs. ≥ 2,500 g) was (aHR = 3.3; 95% CI: 
1.1, 9.9). However, associations between the 
second and third tertiles of p,p´-DDT and 
hypertension increased when adjusted for low 
birth weight (model 2 aHR = 4.0; 95% CI: 
1.9, 8.2 and aHR = 2.9; 95% CI: 1.3, 6.2, 
respectively, and model 3 aHR = 4.0; 95% 
CI: 2.0, 8.0 and aHR = 2.8; 95% CI: 1.4, 
5.9, respectively). There was also no signifi-
cant interaction of either maternal (p = 0.6 
for both tertiles 2 and 3) or daughter BMI 
(p = 0.8 and 0.9 for tertiles 2 and 3, respec-
tively) on the association between prenatal 
p,p´-DDT exposure and medicated hyperten-
sion (model 3, data not shown).
We conducted secondary data analyses of 
alternative exposure classifications. Model 1 
HRs for the association between prenatal 
p,p´-DDT and medicated hypertension were 
1.9 (95% CI: 1.2, 3.1) for p,p´-DDT above 
the median of 9.00 ng p,p´-DDT/mL serum; 
compared with the lowest quartile of exposure, 
the HR for the second (6–9 ng p,p´-DDT/mL 
serum), third (9–13.39 ng p,p´-DDT/mL), and 
fourth quartiles (≥ 13.59 ng p,p´-DDT/mL) 
were 3.0 (95% CI: 1.1, 8.0), 4.5 (95% CI: 1.8, 
11.6), and 3.2 (95% CI: 1.2, 8.7), respectively. 
Further, associations between p,p´-DDT 
and medicated hypertension based on a 
model mutually adjusted for all three DDTs 
(without other covariates) were similar to 
those based on model 1 (tertile 2 HR = 3.5; 
95% CI: 1.7, 7.2 and tertile 3 HR = 2.6; 95% 
CI: 1.1, 6.1).
Associations with prenatal p,p´-DDT and 
hypertension were weaker when the case defi-
nition included all women with a self-reported 
diagnosis of hypertension (n = 111) (model 3 
aHR = 2.1; 95% CI: 1.3, 3.5 and aHR = 1.5; 
95% CI: 0.9, 2.7 for tertiles 2 and 3 rela-
tive to tertile 1, respectively) compared with 
associations with cases limited to women who 
reported using anti hypertensive medication 
only (n = 70, Table 2). HRs increased when 
the oversampled daughters with birth weight 
> 3,835 g were excluded (model 3 aHR = 4.2; 
95% CI: 1.9, 9.3 and 2.8; 95% CI: 1.2 to 
6.9, respectively, n = 345). Last, the unad-
justed association of prenatal p,p´-DDT with 
medicated hypertension was similar when the 
sample was restricted to nonsisters plus either 
the oldest (tertile 2 HR = 2.5; 95% CI: 1.1, 
5.5 and tertile 3 HR = 2.4; 95% CI: 1.1, 5.3, 
n = 61 hypertensives) or second-born (tertile 2 
HR = 2.6; 95% CI: 1.2, 5.9 and tertile 3 
HR = 2.7; 95% CI: 1.2, 6.1, n = 52 hyper-
tensives) sister per sibship (n = 380 total).
Discussion
Summary of principal findings. We observed a 
positive association between prenatal p,p´-DDT 
and self-reported hypertension treated with 
medication in adult women that was robust to 
different modeling assumptions and adjustment 
for several known risk factors. Further, analyses 
of interactions between BMI and DDT were 
consistent with multiplicative joint effects.
Comparison with other studies. Although 
we know of no other studies that have exam-
ined the association between prenatal DDTs 
and offspring hypertension, blood pressure 
has been positively correlated with DDTs 
in the blood of pesticide workers in several 
studies (Morgan et al. 1980; Richardson et al. 
1975; Sandifer et al. 1972). For instance, 
DDT was positively correlated with systolic 
blood pressure in a case–control study of 
South Carolina pesticide workers (Richardson 
et al. 1975). In another study of 120 occupa-
tionally exposed workers and 120 controls, 
systolic and diastolic pressures were positively 
correlated with DDT and DDE in plasma 
(Sandifer et al. 1972). In the largest occupa-
tional cohort study of the association between 
DDT and hypertension (n = 2,597), in which 
all participants were hypertension-free at 
baseline, the mean sum of serum DDTs was 
significantly higher in those who developed 
hypertension 4–6 years later compared with 
those who did not (Morgan et al. 1980). We 
know of only one previous study that assessed 
DDT congeners and blood pressure. Similar 
to associations observed here, the breast 
milk concentration of p,p´-DDT, but not of 
o,p´-DDT or of p,p´-DDE, was associated 
with increased maternal systolic blood pres-
sure in Indian women who were admitted 
to a department of obstetrics and gynecol-
ogy (Siddiqui et al. 2002), which together 
with our findings suggests that the structure 
of DDT congeners may influence their effects 
on blood pressure (Chaturvedi et al. 2010). 
Although our estimated association of hyper-
tension with p,p´-DDT was consistently 
stronger for the second tertile than for the 
third, the lack of significance of this trend in 
our study is aligned with the linear trend in 
p,p´-DDT and systolic blood pressure that 
Siddiqui et al. observed.
Potent ia l  b io logica l  mechanisms . 
Experimental evidence suggests that DDTs 
can act on several arms of the renin angio-
tensin system (RAS) to possibly increase risk 
of hypertension. Gascon and Brodeur (1969) 
showed that angiotensin failed to contract 
guinea pig seminal vesicles ex vivo unless 
pre-treated with DDT. More recent stud-
ies have shown that Na-K-ATPase (sodium 
potassium adenosine triphosphatase) activ-
ity is reduced in prenatally programmed 
hypertensive rats (Alwasel and Ashton 2009; 
Armitage et al. 2005), and in parallel DDTs 
suppressed renal Na-K-ATPase in rainbow 
trout and bluegill fish (Campbell et al. 1974; 
Cutkomp et al. 1971; Davis et al. 1972). This 
body of experimental research together with 
our results suggest that future experimental 
studies should determine whether prenatal 
DDT exposure increases risk of hypertension 
in adult  offspring.
Strengths and weaknesses. The CHDS is 
a prospective birth cohort with clear tem-
poral separation between exposure and out-
come. The CHDS pregnancies occurred near 
the peak of DDT use in the United States, 
allowing us to observe a large range of pre-
natal exposure. Further strengths of the study 
include clinical records of events during preg-
nancy, and quantitative assessment of prenatal 
DDTs from maternal sera.
The primary potential limitation of the 
study is the self-reported health status of the 
adult daughters. We conducted secondary 
data analyses to address this limitation. We 
expected that if prenatal p,p´-DDT exposure 
was a contributing cause of hypertension, 
prenatal p,p´-DDT effects would be more 
pronounced in more severe cases of hyper-
tension. Indeed, we estimated stronger asso-
ciations between prenatal p,p´-DDT exposure 
and self-reported hypertension treated with 
anti hypertensive medication than associations 
with all cases of self-reported hypertension. 
Misclassification of covariables that were self-
reported, such as daughters’ adult weight and 
height, used to calculate daughters’ BMI, could 
also be a potential limitation of this study. 
Although we were unable to internally vali-
date self-reported BMI in the present study, 
comparisons of maternal and daughter adult 
weight, height, and BMI showed expected 
increases among daughters compared to the 
mothers’ generation for all three measures 
(data not shown), similar to secular trends 
observed nationwide (Nooyens et al. 2009; 
Reither et al. 2009). However, oversampling 
La Merrill et al.
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high-birth-weight daughters might have 
resulted in a selection bias that reduced the 
strength of the association between  prenatal 
p,p´-DDT and adult hypertension.
Because DDTs were not measured during 
the life of the daughters and pharmacokinetic 
modeling has not been attempted, we can-
not rule out the possibility that exposure after 
birth contributed to the association between 
prenatal p,p´-DDT exposure and adult hyper-
tension. Although maternal exposure to DDTs 
during both gestation and lactation has been 
positively associated with fetal and neonatal 
DDTs in animals (Woolley and Talens 1971; 
You et al. 1999) and in human cord blood 
(Dorea et al. 2001), lactational p,p´-DDT 
exposure was uncommon for most CHDS 
daughters because of their 34% breastfeeding 
prevalence, which occurred for < 4 months 
duration in 60% of those who breastfed 
(Cohn et al. 2012). Thus our findings likely 
pertain to in utero exposure to p,p´-DDT in 
the majority of CHDS daughters, rather than 
lactational exposure.
Public health implications. DDTs remain 
an important environmental exposure. Each 
year, malaria affects 225 million people 
worldwide, and 781,000 infected people, 
mostly children, die (Agnandji et al. 2011). 
The World Health Organization recom-
mends the use of DDT for indoor malarial 
vector control (Eskenazi et al. 2009). The 
mean serum 15.9 μg p,p´-DDT/L observed 
in children living in areas where DDT is used 
lies within the highest tertile of p,p´-DDT 
in this population (Herrera-Portugal et al. 
2005). The present study suggests that peo-
ple living in DDT-sprayed areas may have 
increased risk of hypertension due to their 
prenatal p,p´-DDT exposure. This adds to 
the existing literature suggesting that adult 
DDT exposure contributes to hypertension 
(Morgan et al. 1980). Because the distribu-
tion of malaria vectors may expand with cli-
mate change (Confalonieri et al. 2007; Rogers 
and Randolph 2000), climate change haz-
ard assessment may benefit from inclusion of 
DDT toxicities, including further evaluation 
of DDT effects on hypertension.
Further, the persistence of DDTs coupled 
with climate dynamics suggests that people 
worldwide will continue to be exposed to 
DDTs that are already in the environment. 
DDT and its metabolite DDE have half-lives 
of about 4 and 10 years in people, respectively 
(Longnecker 2005). Due to their semi volatility, 
DDTs are found far beyond malaria-infested 
regions. For example, melting glaciers contrib-
uted 46% of the DDTs entering the Canadian 
Archipelago, and > 60% of the DDTs entering 
Canadian subalpine lakes (Blais et al. 2001; 
Macdonald et al. 2005). These environmental 
sources of DDTs bio accumulate up the Arctic 
food chain such that intake of DDTs by Inuit 
people is comparable to the intake of DDTs by 
the general population in tropical regions with 
endemic malaria (Ritter et al. 2011).
Conclusions
To our knowledge, our study is the first to 
suggest that hypertension in adult women 
may be increased as a consequence of early-life 
exposure to p,p´-DDT. Womb-to-adult studies 
of hypertension in humans are expensive and 
require long follow-up, thus making studies 
such as ours incredibly rare. Nevertheless, 
examining a larger study sample for an associa-
tion between prenatal p,p´-DDT exposure and 
adult hypertension would be informative, and 
ongoing data collection in the CHDS cohort 
will provide this opportunity. Additional 
critical future research directions would focus 
on replicating our findings experimentally 
to evaluate potential hyper tensive effects of 
p,p´-DDT exposure at different life stages, 
and on examining potential mechanisms of 
p,p´-DDT induced hyper tension, including 
effects through the RAS.
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